Triazolo(4,5-D)pyrimidine compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE46276
SERIAL NO

14976977

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTRAZENECA UK LIMITED1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE CB2 0AA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Guile, Simon Hathern, GB 17 64
Hardem, David Sutton Bonington, GB 1 0
Ingall, Anthony Minehead, GB 15 100
Springthorpe, Brian Stanford on Soar, GB 53 274
Willis, Paul Geneva, CH 34 176

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 17, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00